Endothelium-derived hyperpolarizing factor

Last updated December 15, 2020

In blood vessels Endothelium-Derived Hyperpolarizing Factor or EDHF is proposed to be a substance and/or electrical signal that is generated or synthesized in and released from the endothelium; its action is to hyperpolarize vascular smooth muscle cells, causing these cells to relax, thus allowing the blood vessel to expand in diameter.^[1]

Introduction

The endothelium maintains vascular homeostasis through the release of active vasodilators. Although nitric oxide (NO) is recognized as the primary factor at level of arteries, increased evidence for the role of another endothelium-derived vasodilator known as endothelium-derived hyperpolarizing factor (EDHF) has accumulated in the last years. Experiments show that when NO and Prostacyclin (Vasodilators) are inhibited there is still another factor causing the vessels to dilate^[1] Despite the ongoing debate of its intriguingly variable nature and mechanisms of action, the contribution of EDHF to the endothelium-dependent relaxation is currently appreciated as an important feature of “healthy” endothelium. Since EDHF's contribution is greatest at level of small arteries, the changes in the EDHF action are of critical importance for the regulation of organ blood flow, peripheral vascular resistance , and blood pressure , and in particular when production of NO is compromised. Moreover, depending on the type of cardiovascular disorders altered, EDHF responses may contribute to, or compensate for, endothelial abnormalities associated with pathogenesis of certain diseases. It is widely accepted EDHF plays an important role in vasotone, especially in micro vessels. Its effect varies, depending on the size of the vessel.^[1]

Pathways Of EDHF

There are two general pathways that explain EDH

Diffusible factors are endothelium-derived substances that are able to pass through internal elastic layer (IEL), reach underlying vascular smooth muscle cells at a concentration sufficient to activate ion channels, and initiate smooth muscle hyperpolarization and relaxation.^[1]
Contact-mediated mechanisms bestow endothelial hyperpolarization that passively spreads to the smooth muscle through inter-cellular coupling, and, therefore, EDH is considered as a solely electrical event.^[1]

Discovering the Chemical Identity

Although the phenomenon of EDHF has been observed and reported in scientific literature, to date the chemical identity of the factor(s) has not been determined.

In some cases, members of a class of arachidonic acid derivatives, the epoxyeicosatrienoic acids (EETs), have been found to mediate the vasodilation. These compounds are formed by epoxidation of any one of four double bonds of the arachidonic acid carbon backbone by cytochrome P450 epoxygenase enzymes.^[2]
In addition, in some cases hydrogen peroxide has been suggested to function as an EDHF in some vascular beds;^[3] although the validity of this observation is debated^[4] because it may have an inhibitory action on K+ channels, at least, in some vascular beds.^[1]
It has been suggested that EDHF is potassium ions (K⁺), as the activation of endothelial K-Ca⁺ channels causes an efflux of K⁺ from endothelial cells toward the extracellular space. An increase in extracellular K⁺ has been shown to activate an ouabain-sensitive electrogenic Na⁺–K⁺-ATPase followed by hyperpolarization and smooth muscle cell relaxation. However, the involvement of K⁺ ions in EDHF-mediated relaxation does not necessarily involve the activation Na⁺–K⁺-ATPase channels. It is more likely that K⁺ ions and gap junctions can be involved in EDHF-mediated relaxation simultaneously, and may also act synergistically.^[1]
Subsequently, it was suggested that EDHF is a sulfur signal that results in activation of K channels via sulfhydration of a cysteine residue (formation of a cysteine persulfide) (https://doi.org/10.1161/CIRCRESAHA.111.240242)
C-type natriuretic peptide (CNP) has been shown to exert a variety of cardiovascular effects including vasodilation and hyperpolarization of arteries through the opening of K_Ca⁺-channels. CNP is widely distributed in the cardiovascular system and it has been found at high concentrations, in particular in endothelial cells. Endothelium-derived CNP has been proposed to act as an EDHF via specific C-subtype of natriuretic peptide receptor, however the evidence in favour of CNP's acting as EDHF has yet to be determined.^[1]
An alternative explanation for the EDHF phenomenon is that direct intercellular communication via gap junctions allows passive spread of agonist-induced endothelial hyperpolarization through the vessel wall. In some arteries, eicosanoids and K+ ions may themselves initiate a conducted endothelial hyperpolarization, thus suggesting that electrotonic signalling may represent a general mechanism through which the endothelium participates in the regulation of vascular tone.^[5]

EDHF and Hypertension

Recently, EDHF has been implicated in gender-related differences in blood pressure control. The generation of animals that lack both endothelial nitric oxide synthase (eNOS) and COX-1 (Cyclooxygenase-1, a protein that acts as an enzyme to speed up the production of certain chemical messengers), has allowed a direct assessment of the involvement of EDHF to endothelium-dependent relaxation in small arteries. In mice lacking both eNOS and COX-1, EDHF-mediated response appeared to compensate the absence of endothelial NO in females but not in males. In female mice, the deletion of eNOS and COX-1 did not affect mean arterial blood pressure, while males become hypertensive^[1] In accordance with this study, EDHF has been suggested to be more important in female arteries to confer endothelium-dependent dilatation, while NO played a predominant role in arteries from males. The latter finding indeed concurs with previous reports in several vascular beds, including mesenteric and tail arteries from rats as well as genital arteries from rabbits. These findings together suggest that under pathological conditions EDHF could compensate for the loss of NO in female rather than in male arteries^[1]

Summary

Based on current evidence, the term of endothelium-derived hyperpolarising factor should represent a mechanism rather than a specific factor. The mechanism(s) of endothelium-dependent hyperpolarization (i.e., EDHF-mediated relaxation) seems to be heterogeneous depending on several factors (e.g., size and vascular bed), surrounding environment (oxidative stress, hypercholesterolemia) and demand (compensatory). Different endothelial mediators or pathways involved in EDHF-mediated relaxation may also work simultaneously and/or substitute each other. It implies a reasonable physiological sense, although to some extent and when EDHF acts as backup mechanism for endothelium-dependent relaxation in the present of compromised NO contribution. Thus, alternatives for EDHF-typed responses (H₂O₂, K⁺ etc.) will provide a guarantee for compensation of endothelial function. However, once the involvement of a certain endothelium-derived vasodilator for a given vascular bed is confirmed, it is preferred that they be described by their proper name (i.e., endothelium-derived H₂O₂, or CNP), and no longer be termed as “EDHF”.^[1] Although the role of EDHF in the genesis of Cardiovascular Disease remains to be further elucidated, the EDHF contribution and its importance at the level of small arteries delivers a theoretical opportunity to control systemic blood pressure. There is an increasing experimental evidence to suggest that treatment of the EDHF system could provide a means to control blood pressure and blood flow to target organs in compatible way achieved by manipulations of NO system.

Since “EDHF story” is particularly heterogeneous and based mainly on animal studies, the most important and demanding current task is to strengthen our knowledge about EDHF action in human arteries in health and disease.^[6]

Related Research Articles

Artery Blood vessels that carry blood away from the heart

An artery is a blood vessel that takes blood away from the heart to one or more parts of the body. Most arteries carry oxygenated blood; the two exceptions are the pulmonary and the umbilical arteries, which carry deoxygenated blood to the organs that oxygenate it. The effective arterial blood volume is that extracellular fluid which fills the arterial system.

The blood vessels are the components of the circulatory system that transport blood throughout the human body. These vessels transport blood cells, nutrients, and oxygen to the tissues of the body. They also take waste and carbon dioxide away from the tissues. Blood vessels are needed to sustain life, because all of the body's tissues rely on their functionality.

Atherosclerosis is a disease in which the wall of the artery develops abnormalities, called lesions. These lesions may lead to narrowing due to the buildup of atheromatous plaque. Initially, there are generally no symptoms. When severe, it can result in coronary artery disease, stroke, peripheral artery disease, or kidney problems, depending on which arteries are affected. Symptoms, if they occur, generally do not begin until middle age.

Smooth muscle Involuntary non-striated muscle

Smooth muscle is an involuntary non-striated muscle. It is divided into two subgroups; the single-unit (unitary) and multiunit smooth muscle. Within single-unit cells, the whole bundle or sheet contracts as a syncytium.

Vasodilation is the widening of blood vessels. It results from relaxation of smooth muscle cells within the vessel walls, in particular in the large veins, large arteries, and smaller arterioles. The process is the opposite of vasoconstriction, which is the narrowing of blood vessels.

In biology, depolarization is a change within a cell, during which the cell undergoes a shift in electric charge distribution, resulting in less negative charge inside the cell. Depolarization is essential to the function of many cells, communication between cells, and the overall physiology of an organism.

Endothelium is a single layer of squamous endothelial cells that line the interior surface of blood vessels, and lymphatic vessels. The endothelium forms an interface between circulating blood or lymph in the lumen and the rest of the vessel wall. Endothelial cells form the barrier between vessels and tissue and control the flow of substances and fluid into and out of a tissue.

Mesangial cells are specialised cells in the kidney that make up the mesangium of the glomerulus. Together with the mesangial matrix, they form the vascular pole of the renal corpuscle. The mesangial cell population accounts for approximately 30-40% of the total cells in the glomerulus. Mesangial cells can be categorized as either extraglomerular mesangial cells or intraglomerular mesangial cells, based on their relative location to the glomerulus. The extraglomerular mesangial cells are found between the afferent and efferent arterioles towards the vascular pole of the glomerulus. The extraglomerular mesangial cells are adjacent to the intraglomerular mesangial cells that are located inside the glomerulus and in between the capillaries. The primary function of mesangial cells is to remove trapped residues and aggregated protein from the basement membrane thus keeping the filter free of debris. The contractile properties of mesangial cells have been shown to be insignificant in changing the filtration pressure of the glomerulus.

Prostacyclin (also called prostaglandin I2 or PGI₂) is a prostaglandin member of the eicosanoid family of lipid molecules. It inhibits platelet activation and is also an effective vasodilator.

In vascular diseases, endothelial dysfunction is a systemic pathological state of the endothelium. Along with acting as a semi-permeable membrane, the endothelium is responsible for maintaining vascular tone and regulating oxidative stress by releasing mediators, such as nitric oxide, prostacyclin and endothelin, and controlling local angiotensin-II activity.

In haemodynamics, the body must respond to physical activities, external temperature, and other factors by homeostatically adjusting its blood flow to deliver nutrients such as oxygen and glucose to stressed tissues and allow them to function. Haemodynamic response (HR) allows the rapid delivery of blood to active neuronal tissues. The brain consumes large amounts of energy but does not have a reservoir of stored energy substrates. Since higher processes in the brain occur almost constantly, cerebral blood flow is essential for the maintenance of neurons, astrocytes, and other cells of the brain. This coupling between neuronal activity and blood flow is also referred to as neurovascular coupling.

Nitric oxide synthases (NOSs) are a family of enzymes catalyzing the production of nitric oxide (NO) from L-arginine. NO is an important cellular signaling molecule. It helps modulate vascular tone, insulin secretion, airway tone, and peristalsis, and is involved in angiogenesis and neural development. It may function as a retrograde neurotransmitter. Nitric oxide is mediated in mammals by the calcium-calmodulin controlled isoenzymes eNOS and nNOS. The inducible isoform, iNOS, involved in immune response, binds calmodulin at physiologically relevant concentrations, and produces NO as an immune defense mechanism, as NO is a free radical with an unpaired electron. It is the proximate cause of septic shock and may function in autoimmune disease.

Hyperaemia is the increase of blood flow to different tissues in the body. It can have medical implications but is also a regulatory response, allowing change in blood supply to different tissues through vasodilation. Clinically, hyperaemia in tissues manifest as erythema because of the engorgement of vessels with oxygenated blood. Hyperaemia can also occur due to a fall in atmospheric pressure outside the body. The term is from Greek ὑπέρ + αἷμα.

Variant angina, and less commonly Prinzmetal angina,vasospastic angina, angina inversa, coronary vessel spasm, or coronary artery vasospasm, is a syndrome typically consisting of angina in contrast to stable angina which is generally triggered by exertion or intense exercise, commonly occurs in individuals at rest or even asleep and is caused by vasospasm, a narrowing of the coronary arteries due to contraction of the heart's smooth muscle tissue in the vessel walls. In comparison, stable angina is due to the permanent occlusion of these vessels by atherosclerosis.

The epoxyeicosatrienoic acids or EETs are signaling molecules formed within various types of cells by the metabolism of arachidonic acid by a specific subset of Cytochrome P450 enzymes termed cytochrome P450 epoxygenases. These nonclassic eicosanoids are generally short-lived, being rapidly converted from epoxides to less active or inactive dihydroxy-eicosatrienoic acids (diHETrEs) by a widely distributed cellular enzyme, Soluble epoxide hydrolase (sEH), also termed Epoxide hydrolase 2. The EETs consequently function as transiently acting, short-range hormones; that is, they work locally to regulate the function of the cells that produce them or of nearby cells. The EETs have been most studied in animal models where they show the ability to lower blood pressure possibly by a) stimulating arterial vasorelaxation and b) inhibiting the kidney's retention of salts and water to decrease intravascular blood volume. In these models, EETs prevent arterial occlusive diseases such as heart attacks and brain strokes not only by their anti-hypertension action but possibly also by their anti-inflammatory effects on blood vessels, their inhibition of platelet activation and thereby blood clotting, and/or their promotion of pro-fibrinolytic removal of blood clots. With respect to their effects on the heart, the EETs are often termed cardio-protective. Beyond these cardiovascular actions that may prevent various cardiovascular diseases, studies have implicated the EETs in the pathological growth of certain types of cancer and in the physiological and possibly pathological perception of neuropathic pain. While studies to date imply that the EETs, EET-forming epoxygenases, and EET-inactivating sEH can be manipulated to control a wide range of human diseases, clinical studies have yet to prove this. Determination of the role of the EETS in human diseases is made particularly difficult because of the large number of EET-forming epoxygenases, large number of epoxygenase substrates other than arachidonic acid, and the large number of activities, some of which may be pathological or injurious, that the EETs possess.

Nicorandil is a vasodilatory drug used to treat angina.

Louis J. Ignarro is an American pharmacologist. For demonstrating the signaling properties of nitric oxide, he was co-recipient of the 1998 Nobel Prize in Physiology or Medicine with Robert F. Furchgott and Ferid Murad.

Pathophysiology is a branch of medicine which explains the function of the body as it relates to diseases and conditions. The pathophysiology of hypertension is an area which attempts to explain mechanistically the causes of hypertension, which is a chronic disease characterized by elevation of blood pressure. Hypertension can be classified by cause as either essential or secondary. About 90–95% of hypertension is essential hypertension. Some authorities define essential hypertension as that which has no known explanation, while others define its cause as being due to overconsumption of sodium and underconsumption of potassium. Secondary hypertension indicates that the hypertension is a result of a specific underlying condition with a well-known mechanism, such as chronic kidney disease, narrowing of the aorta or kidney arteries, or endocrine disorders such as excess aldosterone, cortisol, or catecholamines. Persistent hypertension is a major risk factor for hypertensive heart disease, coronary artery disease, stroke, aortic aneurysm, peripheral artery disease, and chronic kidney disease.

Circulating endothelial cells (CECs) are endothelial cells that have been shed from the lining of the vascular wall into the blood stream. Endothelial cells normally line blood vessels to maintain vascular integrity and permeability, but when these cells enter into the circulation, this could be a reflection of vascular dysfunction and damage. There are many factors involved in the process of creating CECs, including: reduced interaction between the endothelial cells and basement membrane proteins, damaged endothelial cellular adhesion molecules, mechanical injury, decreased survival of cytoskeletal proteins, and inflammation.

A resistance artery is small diameter blood vessel in the microcirculation that contributes significantly to the creation of the resistance to flow and regulation of blood flow. Resistance arteries are usually arterioles or end-points of arteries. Having thick muscular walls and narrow lumen they contribute the most to the resistance to blood flow. Degree of the contraction of muscles in the wall of a resistance artery is directly connected to the size of the lumen.

References

1 2 3 4 5 6 7 8 9 10 11 Luksha L, Agewall S, Kublickiene K (February 2009). "Endothelium-derived hyperpolarizing factor in vascular physiology and cardiovascular disease". Atherosclerosis. 202 (2): 330–44. doi:10.1016/j.atherosclerosis.2008.06.008. PMID 18656197.
↑ Fleming I (2014). "The pharmacology of the cytochrome P450 epoxygenase/soluble epoxide hydrolase axis in the vasculature and cardiovascular disease". Pharmacol. Rev. 66: 1106–40. doi: 10.1124/pr.113.007781 . PMID 25244930.
↑ Shimokawa H, Morikawa K (November 2005). "Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in animals and humans". J. Mol. Cell. Cardiol. 39 (5): 725–32. doi:10.1016/j.yjmcc.2005.07.007. PMID 16122755.
↑ You J, Golding EM, Bryan RM (September 2005). "Arachidonic acid metabolites, hydrogen peroxide, and EDHF in cerebral arteries". Am. J. Physiol. Heart Circ. Physiol. 289 (3): H1077–83. doi:10.1152/ajpheart.01046.2004. PMID 15863454.
↑ Griffith, TM (January 2004). "Endothelium-dependent smooth muscle hyperpolarization: do gap junctions provide a unifying hypothesis?". British Journal of Pharmacology. 141 (6): 881–903. doi:10.1038/sj.bjp.0705698. PMC 1574270 . PMID 15028638.
↑ Luksha, L; Agewall, S; Kublickiene, K (2009). "Endothelium-derived hyperpolarizing factor in vascular physiology and cardiovascular disease". Atherosclerosis. 202 (2): 330–44. doi:10.1016/j.atherosclerosis.2008.06.008. PMID 18656197.

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.

[Luksha2009-1] 1 2 3 4 5 6 7 8 9 10 11 Luksha L, Agewall S, Kublickiene K (February 2009). "Endothelium-derived hyperpolarizing factor in vascular physiology and cardiovascular disease". Atherosclerosis. 202 (2): 330–44. doi:10.1016/j.atherosclerosis.2008.06.008. PMID 18656197.

[2] Fleming I (2014). "The pharmacology of the cytochrome P450 epoxygenase/soluble epoxide hydrolase axis in the vasculature and cardiovascular disease". Pharmacol. Rev. 66: 1106–40. doi: 10.1124/pr.113.007781 . PMID 25244930.

[pmid16122755-3] Shimokawa H, Morikawa K (November 2005). "Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in animals and humans". J. Mol. Cell. Cardiol. 39 (5): 725–32. doi:10.1016/j.yjmcc.2005.07.007. PMID 16122755.

[pmid15863454-4] You J, Golding EM, Bryan RM (September 2005). "Arachidonic acid metabolites, hydrogen peroxide, and EDHF in cerebral arteries". Am. J. Physiol. Heart Circ. Physiol. 289 (3): H1077–83. doi:10.1152/ajpheart.01046.2004. PMID 15863454.

[5] Griffith, TM (January 2004). "Endothelium-dependent smooth muscle hyperpolarization: do gap junctions provide a unifying hypothesis?". British Journal of Pharmacology. 141 (6): 881–903. doi:10.1038/sj.bjp.0705698. PMC 1574270 . PMID 15028638.

[6] Luksha, L; Agewall, S; Kublickiene, K (2009). "Endothelium-derived hyperpolarizing factor in vascular physiology and cardiovascular disease". Atherosclerosis. 202 (2): 330–44. doi:10.1016/j.atherosclerosis.2008.06.008. PMID 18656197.

[1]

[2]

[3]

[4]

[5]

[6]